Suicidal behavior and severe neuropsychiatric disorders following glucocorticoid therapy in primary care

American Journal of Psychiatry

Volumn 169, Issue 5, 2012, Pages 491-497

  Fardet, Laurence ^a,b,c,d   Petersen, Irene ^a,b,c,d   Nazareth, Irwin ^a,b,c,d  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b HÔPITAL SAINT ANTOINE   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d Research Department of Primary Care and Population Health   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; DEFLAZACORT; DEXAMETHASONE; GLUCOCORTICOID; HYDROCORTISONE; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; TRIAMCINOLONE;

ADULT; ADVERSE OUTCOME; AGE; ARTICLE; CONFUSION; CONTROLLED STUDY; DELIRIUM; DEPRESSION; DISEASE ASSOCIATION; DISORIENTATION; DRUG EXPOSURE; FEMALE; HIGH RISK PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MANIA; OUTCOME ASSESSMENT; PANIC; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY ANALYSIS; SUICIDE ATTEMPT; UNITED KINGDOM;

EID: 84860516308     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2011.11071009     Document Type: Article

References (36)

1. Schäcke H, Döcke WD, Asadullah K: Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 2002; 96:23-43
2. Daban C, Vieta E, Mackin P, Young AH: Hypothalamic-pituitary-adrenal axis and bipolar disorder. Psychiatr Clin North Am 2005; 28:469-480
3. Claes S: Glucocorticoid receptor polymorphisms in major depression. Ann NY Acad Sci 2009; 1179:216-228
4. Wolkowitz OM, Burke H, Epel ES, Reus VI: Glucocorticoids: mood, memory, and mechanisms. Ann NY Acad Sci 2009; 1179:19-40
5. Brown ES: Effects of glucocorticoids on mood, memory, and the hippocampus: treatment and preventive therapy. Ann NY Acad Sci 2009; 1179:41-55
6. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman LK, Sonino N, Vance ML, Giustina A, Boscaro M: Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab 2003; 88:5593-5602 (Pubitemid 38033020)
7. Kelly WF: Psychiatric aspects of Cushing's syndrome. QJM 1996; 89:543-551
8. Patten SB, Neutel CI: Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis, and management. Drug Saf 2000; 22:111-122 (Pubitemid 30072057)
9. Gift AG, Wood RM, Cahill CA: Depression, somatization, and steroid use in chronic obstructive pulmonary disease. Int J Nurs Stud 1989; 26:281-286
10. Bolanos SH, Khan DA, Hanczyc M, Bauer MS, Dhanani N, Brown ES: Assessment of mood states in patients receiving long-term corticosteroid therapy and in controls with patient-rated and clinician-rated scales. Ann Allergy Asthma Immunol 2004; 92:500-505 (Pubitemid 39236812)
11. Wada K, Yamada N, Sato T, Suzuki H, Miki M, Lee Y, Akiyama K, Kuroda S: Corticosteroid-induced psychotic and mood disorders: diagnosis defined by DSM-IV and clinical pictures. Psychosomatics 2001; 42:461-466 (Pubitemid 34084246)
12. Curtis JR, Westfall AO, Allison J, Bijlsma JW, Freeman A, George V, Kovac SH, Spettell CM, Saag KG: Population-based assessment of adverse events associated with long-term glucocorticoid use. Arthritis Rheum 2006; 55:420-426 (Pubitemid 43887028)
13. Lewis DA, Smith RE: Steroid-induced psychiatric syndromes: a report of 14 cases and a review of the literature. J Affect Disord 1983; 5:319-332 (Pubitemid 14244152)
14. Acute adverse reactions to prednisone in relation to dosage. Clin Pharmacol Ther 1972;13:694-698
15. Appenzeller S, Cendes F, Costallat LT: Acute psychosis in systemic lupus erythematosus. Rheumatol Int 2008; 28:237-243 (Pubitemid 350265464)
16. Wada K, Yamada N, Suzuki H, Lee Y, Kuroda S: Recurrent cases of corticosteroid-induced mood disorder: clinical characteristics and treatment. J Clin Psychiatry 2000; 61:261-267 (Pubitemid 30305367)
17. Lis Y, Mann RD: The VAMP research multi-purpose database in the UK. J Clin Epidemiol 1995; 48:431-443
18. CSD Medical Research/EPIC: THIN Data From EPIC: A Guide for Researchers. London, EPIC, 2007
19. Bourke A, Dattani H, Robinson M: Feasibility study and methodology to create a quality-evaluated database of primary care data. Inform Prim Care 2004; 12:171-177 (Pubitemid 39534583)
20. Lewis JD, Schinnar R, Bilker WB, Wang X, Strom BL: Validation studies of The Health Improvement Network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf 2007; 16:393-401 (Pubitemid 46656860)
21. Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ: Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol 2010; 69:4-14
22. Maguire A, Blak BT, Thompson M: The importance of defining periods of complete mortality reporting for research using automated data from primary care. Pharmacoepidemiol Drug Saf 2009; 18:76-83
23. Lewis JD, Bilker WB, Weinstein RB, Strom BL: The relationship between time since registration and measured incidence rates in the General Practice Research Database. Pharmacoepidemiol Drug Saf 2005; 14:443-451 (Pubitemid 40990739)
24. Chisholm J: The Read clinical classification. BMJ 1990; 300:1092
25. Davé S, Petersen I: Creating medical and drug code lists to identify cases in primary care databases. Pharmacoepidemiol Drug Saf 2009; 18:704-707
26. Walsh LJ, Wong CA, Pringle M, Tattersfield AE: Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. BMJ 1996; 313:344-346 (Pubitemid 26334822)
27. Fardet L, Petersen I, Nazareth I: Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 years. Rheumatology (Oxford) 2011; 50:1982-1990
28. van Staa TP, Leufkens HG, Abenhaim L, Begaud B, Zhang B, Cooper C: Use of oral corticosteroids in the United Kingdom. QJM 2000; 93:105-111 (Pubitemid 30098773)
29. Fardet L, Flahault A, Kettaneh A, Tiev KP, Toledano C, Lebbe C, Cabane J: Corticosteroid-induced clinical adverse events: frequency, risk factors, and patient's opinion. Br J Dermatol 2007; 157:142-148 (Pubitemid 46934268)
30. Warrington TP, Bostwick JM: Psychiatric adverse effects of corticosteroids. Mayo Clin Proc 2006; 81:1361-1367 (Pubitemid 44484975)
31. Patten SB: Exogenous corticosteroids and major depression in the general population. J Psychosom Res 2000; 49:447-449
32. Brown ES, Suppes T, Khan DA, Carmody TJ 3rd: Mood changes during prednisone bursts in outpatients with asthma. J Clin Psychopharmacol 2002; 22:55-61 (Pubitemid 34101293)
33. Goolker P, Schein J: Psychic effects of ACTH and cortisone. Psychosom Med 1953; 15:589-612
34. Hall RC, Popkin MK, Stickney SK, Gardner ER: Presentation of the steroid psychoses. J Nerv Ment Dis 1979; 167:229-236 (Pubitemid 9167954)
35. Rait G, Walters K, Griffin M, Buszewicz M, Petersen I, Nazareth I: Recent trends in the incidence of recorded depression in primary care. Br J Psychiatry 2009; 195:520-524
36. Reckart MD, Eisendrath SJ: Exogenous corticosteroid effects on mood and cognition: case presentations. Int J Psychosom 1990; 37:57-61 (Pubitemid 20380400)